# Governor Polis Supports Federal Rescheduling of Medical Marijuana > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-cannabis-federal-rescheduling-medical-marijuana/ > **Published:** 2026-04-23T21:09:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:14:08-04:00 > **Clinical Summary:** Explore how 2026 cannabis federal rescheduling removes research barriers and advances medical marijuana studies and clinical evidence. --- ✦ New CED Clinical Relevance  #88High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PolicyMedical CannabisResearchFederal RegulationClinical Evidence Why This Matters Federal rescheduling from Schedule I to Schedule III would remove the greatest regulatory barrier to rigorous [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/), potentially enabling the controlled studies needed to establish evidence-based dosing protocols. This shift could fundamentally change how clinicians access reliable data to guide patient care decisions. Clinical Summary The federal government is moving to reschedule cannabis from Schedule I (no accepted medical use) to Schedule III (accepted medical use with moderate dependence potential). This administrative change would align federal classification with the medical cannabis programs already operating in 38 states. Schedule III status maintains controlled substance oversight while removing research restrictions that have limited clinical evidence generation for decades. Dr. Caplan’s Take “I’ve been practicing [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) for years with essentially no federal research support—we’ve been flying blind with clinical intuition where we need controlled trials. This rescheduling won’t immediately change what’s in dispensaries, but it opens the door to the research infrastructure that could finally give us the dosing studies and safety data we desperately need.” Clinical Perspective 🧠 Clinicians should expect this change to unfold over months, not days, with immediate practice implications limited. The real value will emerge over years as research institutions gain ability to conduct federally-funded studies. Patients should understand that rescheduling doesn’t change current state medical programs or product availability—it’s a research and regulatory foundation shift. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Governor%20Polis%20Welcomes%20Federal%20Action%20to%20Reschedule%20Medical%20Marijuana%20%40drcaplan&url=https%3A//governorsoffice.colorado.gov/governor/news/governor-polis-welcomes-federal-action-reschedule-medical-marijuana)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//governorsoffice.colorado.gov/governor/news/governor-polis-welcomes-federal-action-reschedule-medical-marijuana)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Governor%20Polis%20Welcomes%20Federal%20Action%20to%20Reschedule%20Medical%20Marijuana%20--%20via%20%40drcaplan.bsky.social%20https%3A//governorsoffice.colorado.gov/governor/news/governor-polis-welcomes-federal-action-reschedule-medical-marijuana)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://governorsoffice.colorado.gov/governor/news/governor-polis-welcomes-federal-action-reschedule-medical-marijuana](https://governorsoffice.colorado.gov/governor/news/governor-polis-welcomes-federal-action-reschedule-medical-marijuana) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover) - [Is this recent news about medical cannabis?](#Is_this_recent_news_about_medical_cannabis) - [What makes this cannabis news clinically significant?](#What_makes_this_cannabis_news_clinically_significant) - [Who should pay attention to this cannabis policy update?](#Who_should_pay_attention_to_this_cannabis_policy_update) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned a “High Clinical Relevance” rating (#88) by CED Clinical standards. This indicates the content has strong evidence or policy relevance with direct clinical implications for healthcare providers. #### What type of cannabis-related content does this article cover? The article focuses on medical cannabis policy and federal regulation topics. It appears to be research-based content that has direct implications for clinical practice. #### Is this recent news about medical cannabis? Yes, this article is marked as “New” content from CED Clinic’s cannabis news section. It represents the latest developments in medical cannabis policy and regulation. #### What makes this cannabis news clinically significant? The high clinical relevance rating suggests this news contains important policy changes or research findings that will directly impact how healthcare providers approach [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/). The federal regulation tag indicates potential changes to prescribing or treatment protocols. #### Who should pay attention to this cannabis policy update? Healthcare providers, medical cannabis researchers, and clinicians involved in cannabis treatment should review this content. The clinical relevance rating indicates it contains actionable information for medical professionals working with [cannabis therapies](https://cedclinic.com/deep-reading-decline-digital-age-insights/). [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Federal reclassification of marijuana could 'turbocharge' Vermont's medical market](https://cedclinic.com/federal-marijuana-reclassification-vermont-medical-market/) Learn how federal reclassification is expected to boost Vermont’s medical marijuana market and research opportunities. [Read More](https://cedclinic.com/federal-marijuana-reclassification-vermont-medical-market/) [Federal reclassification of medical marijuana opens new research doors for Colorado scientists](https://cedclinic.com/federal-rescheduling-medical-marijuana-research-access/) Discover how Colorado scientists benefit from federal reclassification enabling expanded [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). [Explore Article](https://cedclinic.com/federal-rescheduling-medical-marijuana-research-access/) [Rescheduling marijuana would open the doors for researchers to study THC and CBD.](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) This article explains how rescheduling marijuana facilitates critical research on THC and CBD compounds. [Learn More](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).